Stage FocusSeed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechSynthetic Biology
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Third Rock Ventures was founded in 2007 by Kevin Starr, Mark Levin, and Robert Tepper, all former executives at Millennium Pharmaceuticals. The firm has raised $3.8B in total, including a $1.1B Fund VI in 2022, and was ranked the #1 biotech VC by STAT for returns.
The model is "Discover. Launch. Build. Transform." — Third Rock builds companies from scratch rather than simply investing in existing...
Notable Investments
R
Relay TherapeuticsB
Blueprint MedicinesF
Foundation MedicineF
Fulcrum TherapeuticsA
AgiosB
Bluebird BioSimilar Funds
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
Atlas Venture
Cambridge, United States
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
MB
Mission Bay Capital
San Francisco, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
PS
Panacea Stars
Oxford, United Kingdom
Pure DeepTechBiotechAIMedtechPre-SeedSeed
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A